Cardiac Tissue Models

Beating Cardiac Bodies

 iPSC-Derived Beating Cardiac Bodies -A Complete Workflow

Stem cell–derived cardiomyocytes are becoming essential tools in cardiovascular research, disease modeling, and drug discovery. The CERO 3D Incubator & Bioreactor simplifies this entire workflow by enabling efficient stem cell expansion into uniform aggregates, followed by direct induction into high-yield, beating cardiac bodies.

Compared to traditional orbital shakers, CERO 3D delivers superior cell quality, homogeneity, integrity, and yield during stem cell expansion and cardiac differentiation.

CERO 3D versus Orbital Shaker

Differentiation of murine embryonic stem cell-derived cardiomyocytes at days 3, 8, and 13 post-induction (from top to bottom).

Purified and homogeneous cardiac bodies generated in CERO 3D Incubator & Bioreactor are perfect tools for disease modeling and drug discovery. The pure cardiomyocytes can also be used in 2D downstream monolayer applications.

Key Advantages:

  • Homogeneous 3D aggregates in suspension
  • Expansion and differentiation in the same CEROtube
  • Easy to handle & standardize
  • Highest yield, no substrate required
  • Greater relevance for drug testing and disease modeling

Publication: differentiation and dissociation of hiPSC-derived cardiospheres



Scale up your cardiac tissue research with CERO 3D.

Request a Free Demo Today!


​​​​​​​​​​Request a Free Demo​​​​​​​​